ONGLYZA + MET Canadian Trademark Information
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations relating to metabolic disorders, namely, diabetes, obesity hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-infectives, central nervous system stimulants, anti-psychotics and pharmaceutical antibodies.
Perfect for these industries
Words that describe this mark
pharmaceutical preparations human use treatment prevention obesity diabetes incontinence cardiovascular diseases stroke cancer respiratory diseases autoimmune diseases solid organ transplant rejection pharmaceutical preparations relating metabolic disorders diabetes
Abandonment Notice!
On Wednesday, March 28, 2012,
status on the ONGLYZA + MET
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Monday, March 9, 2009, a canadian trademark registration was filed for
ONGLYZA + MET by Bristol-Myers Squibb Company
( *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1430316.
The current status of this trademark filing is Interruption of proceeding.
The correspondent listed for
ONGLYZA + MET is
GOWLING WLG (CANADA) LLP of *********, **********, ***** ****
The ONGLYZA + MET
trademark is filed in the description of
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations relating to metabolic disorders, namely, diabetes, obesity hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-infectives, central nervous system stimulants, anti-psychotics and pharmaceutical antibodies.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.